Thursday, December 05, 2019 8:30:54 PM
Hey Chunky, obviously if the LAH*O shares were coming in on a one for one basis, that would be the case... that's not what I believe to be happening. Take a look at my other posts discussing the matter and you'll see why I've decided to build a modest position. This actually covers me in either case (i.e. even IF it does end up being 1 for 1) but I haven't bet more than I can afford to lose.
I know some mentioned the AS increase to 6.5B corresponded with the GSCG news, but if you look back at the filings you'll see that this AS was carried over from PNOW when the RS and ticker change took place. I think by merging into the lower OS situation, GSCG will avoid doing the RS that was inevitable in LAH*O. That's enough to get me to buy a few tickets...
$MSSV$
I know some mentioned the AS increase to 6.5B corresponded with the GSCG news, but if you look back at the filings you'll see that this AS was carried over from PNOW when the RS and ticker change took place. I think by merging into the lower OS situation, GSCG will avoid doing the RS that was inevitable in LAH*O. That's enough to get me to buy a few tickets...
$MSSV$
Recent RMTG News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2026 03:05:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/14/2026 09:20:25 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 03:48:57 PM
- RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind • ACCESS Newswire • 03/26/2026 11:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 10:12:56 PM
- RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit • ACCESS Newswire • 11/18/2025 12:59:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:59:17 PM
- RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership • ACCESS Newswire • 10/21/2025 11:59:00 AM
- RMTG Expands into Brazil with Strategic Representation Agreement • ACCESS Newswire • 10/14/2025 11:59:00 AM
- RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries • ACCESS Newswire • 10/08/2025 11:59:00 AM
- RMTG Partners with BKFC as Official Regenerative Medicine Provider • ACCESS Newswire • 09/29/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 08:32:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2025 08:06:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/30/2025 04:15:10 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/12/2025 01:56:55 AM
